Meglumine Antimoniate
- Glucantime
- meglumine antimoniate
- Meglumine antimonate
- N-Methylglucamine antimonate
- 133-51-7
- Create:2005-08-08
- Modify:2025-01-18
- Glucantime
- meglumine antimoniate
- N Methylglucamine Antimonate
- N-methylglucamine antimonate
- Glucantime
- meglumine antimoniate
- Meglumine antimonate
- N-Methylglucamine antimonate
- 133-51-7
- Methylglucamine antimonate
- Protostib
- 2168-RP
- EINECS 205-108-3
- n-methyl glucamine antimoniate
- UNII-75G4TW236W
- 75G4TW236W
- 1-Deoxy-1-(methylamino)glucitol antimonate(V)
- DTXSID4043935
- MEGLUMINE ANTIMONATE [WHO-DD]
- D-Glucitol, 1-deoxy-1-(methylamino)-, trioxoantimonate(1-)
- N-METHYLGLUCAMINE ANTIMONATE [MI]
- N-Methylgluamine Antimoniate
- Glucantim
- Glucantime (TN)
- 1-Deoxy-1-(methylamino)-D-glucitol, compound with antimonic acid (1:1)
- SCHEMBL146372
- DTXCID2023935
- MFCD01725422
- AKOS025310684
- DB13732
- Q2757969
- (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol stibenate
- (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; oxostibinic acid
H302 (50%): Harmful if swallowed [Warning Acute toxicity, oral]
H332 (50%): Harmful if inhaled [Warning Acute toxicity, inhalation]
H411 (50%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
P261, P264, P270, P271, P273, P301+P317, P304+P340, P317, P330, P391, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 2 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Reported as not meeting GHS hazard criteria per 1 of 2 reports by companies. For more detailed information, please visit ECHA C&L website.
There is 1 notification provided by 1 of 2 reports by companies with hazard statement code(s).
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 4 (50%)
Acute Tox. 4 (50%)
Aquatic Chronic 2 (50%)
- ChemIDplusMeglumine antimoniatehttps://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000133517ChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DrugBankLICENSECreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)https://www.drugbank.ca/legal/terms_of_useMeglumine antimoniatehttps://www.drugbank.ca/drugs/DB13732
- EPA DSSToxMeglumine antimonatehttps://comptox.epa.gov/dashboard/DTXSID4043935CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-notice1-deoxy-1-(methylamino)-D-glucitol, compound with antimonic acid (1:1)https://echa.europa.eu/substance-information/-/substanceinfo/100.004.6451-deoxy-1-(methylamino)-D-glucitol, compound with antimonic acid (1:1) (EC: 205-108-3)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/71780
- FDA Global Substance Registration System (GSRS)LICENSEUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.https://www.fda.gov/about-fda/about-website/website-policies#linkingMEGLUMINE ANTIMONIATEhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/75G4TW236W
- ClinicalTrials.govLICENSEThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jspMeglumine Antimoniatehttps://ctdbase.org/detail.go?type=chem&acc=D000077485
- Therapeutic Target Database (TTD)Meglumine antimoniatehttps://idrblab.net/ttd/data/drug/details/D0T6VD
- Metabolomics WorkbenchMeglumine antimoniatehttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=154517
- WHO Anatomical Therapeutic Chemical (ATC) ClassificationLICENSEUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.https://www.whocc.no/copyright_disclaimer/Meglumine antimonatehttps://www.whocc.no/atc_ddd_index/?code=P01CB01
- WHO Model Lists of Essential MedicinesLICENSEPermission from WHO is not required for the use of WHO materials issued under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Intergovernmental Organization (CC BY-NC-SA 3.0 IGO) license.https://www.who.int/about/policies/publishing/copyrightMeglumine antimoniatehttps://list.essentialmeds.org/medicines/370
- Wikidatameglumine antimoniatehttps://www.wikidata.org/wiki/Q2757969
- WikipediaSodium stibogluconatehttps://en.wikipedia.org/wiki/Sodium_stibogluconateMeglumine antimoniatehttps://en.wikipedia.org/wiki/Meglumine_antimoniate
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.htmlMeglumine Antimoniatehttps://www.ncbi.nlm.nih.gov/mesh/2028047Antiprotozoal Agentshttps://www.ncbi.nlm.nih.gov/mesh/68000981
- PubChem
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- NORMAN Suspect List ExchangeLICENSEData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0https://creativecommons.org/licenses/by/4.0/NORMAN Suspect List Exchange Classificationhttps://www.norman-network.com/nds/SLE/
- EPA Substance Registry ServicesEPA SRS List Classificationhttps://sor.epa.gov/sor_internet/registry/substreg/LandingPage.do
- NCBI